Merck (MRK) Non-Current Debt (2009 - 2026)

Merck (MRK) has reported Non-Current Debt for 18 consecutive years, with $51.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Debt rose 50.38% year-over-year to $51.1 billion in Q2 2026; TTM through Jun 2026 was $51.1 billion, a 50.38% increase from a year earlier, with the FY2025 full-year figure at $46.8 billion, up 35.66% from the prior year.
• Non-Current Debt was $51.1 billion for Q2 2026 at Merck, up from $46.7 billion in the prior quarter.
• Over five years, Non-Current Debt peaked at $51.1 billion in Q2 2026 and troughed at $28.1 billion in Q1 2023.
• A 5-year average of $35.2 billion and a median of $34.0 billion in 2023 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt declined 8.21% in 2023 and surged 50.38% in 2026, its largest moves.
• Over 5 years, Non-Current Debt stood at $28.7 billion in 2022, then gained by 17.18% to $33.7 billion in 2023, then climbed by 2.31% to $34.5 billion in 2024, then soared by 35.66% to $46.8 billion in 2025, then climbed by 9.26% to $51.1 billion in 2026.
• The last three Non-Current Debt figures came in at $51.1 billion (Q2 2026), $46.7 billion (Q1 2026), and $46.8 billion (Q4 2025), per Business Quant data.